Update of survey, regulation and toxic effects of mycotoxins in Europe

Abado-Becognee, 1998, Cytotoxicity of fumonisin B1: implication of lipid peroxidation and inhibition of protein and DNA syntheses, Arch. Toxicol., 72, 233, 10.1007/s002040050494

Bacha, H., Hadidane, R., Ellouz, F., Creppy, E.E., 1993, Effects of zearalenone on fertilisation and gestation in rats, In: Scudamore, K.A. (Ed.), Occurrence and Significance of Mycotoxins, Central Science Laboratory, The University of West London (UK), pp. 258–262.

Baudrimont, 1997, Reduction of the ochratoxin A-induced cytotoxicity in vero cells by aspartame, Arch. Toxicol., 71, 290, 10.1007/s002040050389

Baudrimont, 2001, Aspartame prevents the karyomegaly induced by ochratoxin A in rat kidney, Arch. Toxicol., 75, 176, 10.1007/s002040100229

Becci, 1982, Long-term carcinogenicity and toxicity study of zearalenone in the rat, J. Appl. Toxicol., 2, 247, 10.1002/jat.2550020507

Belmadani, 1998, Subchronic effects of ochratoxin A on young adult rat brain and partial prevention by aspartame, a sweetener, Hum. Exp. Toxicol., 17, 380, 10.1191/096032798678908981

Creppy, 1996, Aspartame as a preventive agent of chronic effects of ochratoxin A in experimental animals, Food Addit. Contam., 13, 51

Creppy, 1985, Genotoxicity of ochratoxin A in mice: DNA single-strand breaks evaluation in spleen, liver and kidney, Toxicol. Lett., 28, 29, 10.1016/0378-4274(85)90006-2

Creppy, 1999, Human ochratoxicosis, J.Toxicol. Toxin Rev., 18, 277, 10.3109/15569549909009258

Creppy, 2000, Preventive effects of aspartame on the genotoxic effects of ochratoxin A in vivo, 119

Eriksen, G.S., Alexander, J., 1998, In: Nordic Council of Ministers. (Ed.), Fusarium toxins in cereals—a risk assessment, Tema Nord, Copenhagen, 502, 7–58.

Froquet, 2000, In vitro sensitivity of platelet (CFU-MK) to trichothecene mycotoxins, Hum. Exp. Toxicol., 19, 473

Gelderbrom, 1992, Fumonisins: isolation, chemical characterisation and biological effects, Mycopathologia, 117, 11, 10.1007/BF00497273

Ghedira-Chekir, 1998, Induction of SOS repair system in lysogenic bacteria by zearalenone and its prevention by vitamin E, Chem. Biol. Interact., 113, 15, 10.1016/S0009-2797(98)00013-1

Ghedira-Chekir, 1999, Cytotoxicity and genotoxicity of zearalenone: prevention by vitamin E, J. Toxicol. Toxin Rev., 18, 355, 10.3109/15569549909162652

Grosse, 1997, Retinol, ascorbic acid and alpha tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone, Cancer Lett., 114, 225, 10.1016/S0304-3835(97)04669-7

IARC, 1993. Monographs on the evaluation of the carcinogenic risk of chemicals to humans: some naturally occurring substances. Food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, France. Vol. 56, pp. 397–444.

IARC, 1999. Overall evaluations of carcinogenicity to humans. IARC monographs, Vol. 1–73, pp.1–36.

JECFA 2000. Joint FAO/WHO Expert Committee on Food Additives, 53rd Report. Safety evaluation of certain food additives. WHO Food Additives Series 44.

Kane, 1986, Distribution of the [3H]-label from low doses of radioactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys, Arch. Toxicol., 58, 219, 10.1007/BF00297109

Kuiper-Goodman, 1987, Risk assessment of the mycotoxin zearalenone, Reg. Toxicol. Pharmacol., 7, 253, 10.1016/0273-2300(87)90037-7

Maaroufi, 1996, Zearalenone induces modifications of haematological and biochemical parameters in rats, Toxicon., 34, 534, 10.1016/0041-0101(96)00008-6

Maaroufi, 1999, Karyomegaly of tubular cells as early stage marker of nephrotoxicity induced by ochratoxin A in rats, Human Exp. Toxicol., 18, 410, 10.1191/096032799678840192

Mobio, 2000, Epigenetic properties of fumonisin B1: cell cycle arrest and DNA base modification in C6 glioma cells, Toxicol. Appl. Pharm., 164, 91, 10.1006/taap.2000.8893

NTP 1982. Carcinogenicity bioassay of zearalenone in F344/N rats and F6C3F1 mice. National Toxicology Program Technical Report Series 235. Research Triangle Park, NC.

Obrecht-Pflumio, 2000, In vitro DNA and dGMP adducts formation caused by ochratoxin A, Chem. Biol. Interact., 127, 29, 10.1016/S0009-2797(00)00169-1

Petkova-Bocharova, 1988, Ochratoxin A in human blood in relation to Balkan Endemic Nephropathy and urinary system tumours in Bulgaria, Food Addit. Contam., 5, 299, 10.1080/02652038809373707

Pfohl-Leszkowicz, A., Grosse, Y., Castegnero, M., Petkova-Bocharova, T., Nicolov, I.G., Chernozemsky, I.N., Bartsch, H., Betbeder, A.M., Creppy, E.E., Dirheimer, G.,1993. Similarity between ochratoxin A-induced DNA-adducts in mice and DNA-adducts in urinary tracts tumours in humans with Balkan endemic nephropathy. In: Scudamore, K.A. (Ed.), Occurrence and Significance of Mycotoxins, The University of West London (UK):Central Science Laboratory 239–243.

Pfohl-Leszkowicz, 1994, Genotoxicity and DNA binding of ochratoxin A a ubiquitous mycotoxin found in food and feed, 51

Riley, 1993, Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs, Toxicol. Appl. Pharm., 118, 105, 10.1006/taap.1993.1015

Rio, 2000, Human haematopoietic progenitors sensitivity to food contaminant mycotoxin: ochratoxin A, Hum. Exp. Toxicol., 19, 473

Stander, 2001, Toxicokinetics of ochratoxin A in vervet monkeys (Cercopithecus aethiops), Arch. Toxicol., 75, 262, 10.1007/s002040100227

Szuetz, 1997, Early telearche symptoms in children and their relations to zearalenone contamination in foodstuffs, Cereals Res. Com., 25, 429, 10.1007/BF03543747

Tomaszewski, 1998, Tissue zearalenone concentration in normal, hyperplastic and neoplastic human endometrium, Ginekol. Pol., 69, 363